Approval · Notice of Compliance 22892 · 2019
ZANTAC: Notice of Compliance 22892
Issued November 7, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22892
- Date
- November 7, 2019
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To align labels with PLL requirements, to harmonize Part 1 of the PM with Part III
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANTAC | Not yet assigned | — |
| ZANTAC MAXIMUM STRENGTH NON-PRESCRIPTION | Not yet assigned | — |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB
- RANITIDINE HCL 150 MG per TAB